Testing for HIV prior to methotrexate administration. Is it an obligatory procedure? [12]

International Journal of Dermatology

Volumn 45, Issue 8, 2006, Pages 998-999

  Chernyshov, Pavel ^a  

^a BOGOMOLETS NATIONAL MEDICAL UNIVERSITY   (Ukraine)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

CLINICAL FEATURE; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DRUG CONTRAINDICATION; FREQUENCY ANALYSIS; HEALTH CARE COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; LETTER; MAJOR CLINICAL STUDY; NONHUMAN; OPPORTUNISTIC INFECTION; PATIENT ASSESSMENT; PHOTOTHERAPY; PSORIASIS; PSORIATIC ARTHRITIS; RISK ASSESSMENT; SAFETY; SERODIAGNOSIS; SKIN MANIFESTATION; TREATMENT OUTCOME; UKRAINE;

ADULT; ARTHRITIS, PSORIATIC; DERMATOLOGIC AGENTS; HIV INFECTIONS; HIV-1; HUMANS; METHOTREXATE;

EID: 33746645969     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2006.02746.x     Document Type: Letter

References (6)

1. Mallon E, Bunker CB. HIV-associated psoriasis. AIDS Patient Care STDS 2000; 14: 239-246.
2. Vogel J, Cepeda M, Tschachler E, et al. UV activation of human immunodeficiency virus gene expression in transgenic mice. J Virol 1992; 66: 1-5.
3. Breuer-McHam J, Marshall G, Adu-Oppong A, et al. Alterations in HIV expression in AIDS patients with psoriasis or pruritus treated with phototherapy. J Am Acad Dermatol 1999; 40: 48-60.
4. Schoppelrey HP, Breit R. UV-therapy in HIV-infected patients. Hautarzt 1999; 50: 643-648.
5. Winchester R. Psoriatic arthritis. Dermatol Clin 1995; 13: 779-792.
6. Maurer TA, Zackheim HS, Tuffanelli L, et al. The use of methotrexate for treatment of psoriasis in patients with HIV infection. J Am Acad Dermatol 1994; 31: 372-375.